One year of Tysabri (natalizumab) improves working ability among people with relapsing-remitting multiple sclerosis (RRMS), according to new data from TITAN, an observational study launched by resear… [+5259 chars]
Tysabri infusion improves working ability for RRMS patients: Study - Multiple Sclerosis News Today
One year of Tysabri infusion improved working ability for relapsing-remitting multiple sclerosis (RRMS) patients in France, per TITAN data.
By:Steve Bryson, PhD
Source:Multiple Sclerosis News Today
Published:
Related News
This Is the Vaccine Story RFK Jr. Doesn’t Want You to Hear - The Bulwark
The Trump administration says we should learn from other countries. Maybe they should have looked someplace besides Denmark.
The Bulwark•Jonathan Cohn
Close to 90% of Americans have silent heart disease, AHA says - NewsNation
The AHA acknowledged that Cardiovascular-Kidney-Metabolic syndrome (CKM) is a condition that involves a chain reaction inside the body.
Newsnationnow.com•Rob Taub
This Forgotten Cancer Vaccine’s Results Were So Unusual Scientists Revisited It 20 Years Later - SciTechDaily
New research suggests that a breast cancer vaccine developed decades ago may have triggered a lasting immune memory response that can now be significantly boosted by a newly developed antibody.
SciTechDaily